Kooth (KOO) Competitors

Kooth logo
GBX 180 -5.00 (-2.70%)
As of 11/17/2026 08:03 AM Eastern

KOO vs. INS, RENX, COG, INHC, and IQAI

Should you buy Kooth stock or one of its competitors? Kooth's main competitors and comparable companies include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), and IQ-AI (IQAI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Kooth compare to Instem?

Instem (LON:INS) and Kooth (LON:KOO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Kooth has a net margin of 9.43% compared to Instem's net margin of 5.50%. Kooth's return on equity of 17.74% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Instem5.50% 6.35% 4.62%
Kooth 9.43%17.74%10.12%

Instem has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market. Comparatively, Kooth has a beta of 1.34, suggesting that its share price is 34% more volatile than the broader market.

In the previous week, Instem had 3 more articles in the media than Kooth. MarketBeat recorded 3 mentions for Instem and 0 mentions for Kooth. Instem's average media sentiment score of 0.11 beat Kooth's score of 0.00 indicating that Instem is being referred to more favorably in the media.

Company Overall Sentiment
Instem Neutral
Kooth Neutral

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Instem£61.63M0.00£3.34M£0.14N/A
Kooth£62.02M1.06£4.00M£15.0012.00

65.9% of Instem shares are owned by institutional investors. Comparatively, 21.0% of Kooth shares are owned by institutional investors. 30.0% of Instem shares are owned by insiders. Comparatively, 30.4% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Kooth has a consensus price target of GBX 345, indicating a potential upside of 91.67%. Given Kooth's stronger consensus rating and higher possible upside, analysts plainly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Kooth beats Instem on 11 of the 15 factors compared between the two stocks.

How does Kooth compare to Renalytix?

Renalytix (LON:RENX) and Kooth (LON:KOO) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

Kooth has a net margin of 9.43% compared to Renalytix's net margin of -506.25%. Renalytix's return on equity of 675.00% beat Kooth's return on equity.

Company Net Margins Return on Equity Return on Assets
Renalytix-506.25% 675.00% -93.54%
Kooth 9.43%17.74%10.12%

Kooth has a consensus target price of GBX 345, suggesting a potential upside of 91.67%. Given Kooth's stronger consensus rating and higher possible upside, analysts clearly believe Kooth is more favorable than Renalytix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Renalytix
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Renalytix's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company Overall Sentiment
Renalytix Neutral
Kooth Neutral

Kooth has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Renalytix£3M12.29-£109.93M-£3.00N/A
Kooth£62.02M1.06£4.00M£15.0012.00

Renalytix has a beta of 1.707, suggesting that its stock price is 71% more volatile than the broader market. Comparatively, Kooth has a beta of 1.34, suggesting that its stock price is 34% more volatile than the broader market.

14.0% of Renalytix shares are held by institutional investors. Comparatively, 21.0% of Kooth shares are held by institutional investors. 3.9% of Renalytix shares are held by company insiders. Comparatively, 30.4% of Kooth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Kooth beats Renalytix on 11 of the 14 factors compared between the two stocks.

How does Kooth compare to Cambridge Cognition?

Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, media sentiment, profitability, risk and earnings.

Kooth has a net margin of 9.43% compared to Cambridge Cognition's net margin of -13.86%. Kooth's return on equity of 17.74% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth9.43% 17.74% 10.12%
Cambridge Cognition -13.86%-54.17%-0.30%

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£62.02M1.06£4.00M£15.0012.00
Cambridge Cognition£10.13M1.59-£1.58M-£3.10N/A

21.0% of Kooth shares are held by institutional investors. Comparatively, 13.1% of Cambridge Cognition shares are held by institutional investors. 30.4% of Kooth shares are held by insiders. Comparatively, 3.3% of Cambridge Cognition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Cambridge Cognition had 1 more articles in the media than Kooth. MarketBeat recorded 1 mentions for Cambridge Cognition and 0 mentions for Kooth. Cambridge Cognition's average media sentiment score of 0.38 beat Kooth's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company Overall Sentiment
Kooth Neutral
Cambridge Cognition Neutral

Kooth has a beta of 1.34, indicating that its stock price is 34% more volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.809, indicating that its stock price is 19% less volatile than the broader market.

Kooth currently has a consensus price target of GBX 345, indicating a potential upside of 91.67%. Cambridge Cognition has a consensus price target of GBX 56, indicating a potential upside of 87.29%. Given Kooth's higher possible upside, research analysts plainly believe Kooth is more favorable than Cambridge Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Kooth beats Cambridge Cognition on 12 of the 15 factors compared between the two stocks.

How does Kooth compare to Induction Healthcare Group?

Kooth (LON:KOO) and Induction Healthcare Group (LON:INHC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

Kooth presently has a consensus price target of GBX 345, suggesting a potential upside of 91.67%. Given Kooth's stronger consensus rating and higher possible upside, equities research analysts clearly believe Kooth is more favorable than Induction Healthcare Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Induction Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has a beta of 1.34, indicating that its share price is 34% more volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, indicating that its share price is 141% less volatile than the broader market.

Kooth has a net margin of 9.43% compared to Induction Healthcare Group's net margin of -23.86%. Kooth's return on equity of 17.74% beat Induction Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth9.43% 17.74% 10.12%
Induction Healthcare Group -23.86%-14.58%-7.32%

Kooth has higher revenue and earnings than Induction Healthcare Group. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£62.02M1.06£4.00M£15.0012.00
Induction Healthcare Group£12.57M0.72-£5.12M-£5.54N/A

21.0% of Kooth shares are owned by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are owned by institutional investors. 30.4% of Kooth shares are owned by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Kooth's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Kooth Neutral
Induction Healthcare Group Neutral

Summary

Kooth beats Induction Healthcare Group on 12 of the 14 factors compared between the two stocks.

How does Kooth compare to IQ-AI?

Kooth (LON:KOO) and IQ-AI (LON:IQAI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

Kooth has a beta of 1.34, meaning that its stock price is 34% more volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, meaning that its stock price is 125% more volatile than the broader market.

Kooth presently has a consensus price target of GBX 345, suggesting a potential upside of 91.67%. Given Kooth's stronger consensus rating and higher possible upside, equities analysts clearly believe Kooth is more favorable than IQ-AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
IQ-AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Kooth has a net margin of 9.43% compared to IQ-AI's net margin of -77.52%. Kooth's return on equity of 17.74% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth9.43% 17.74% 10.12%
IQ-AI -77.52%-140.75%-22.03%

Kooth has higher revenue and earnings than IQ-AI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£62.02M1.06£4.00M£15.0012.00
IQ-AI£538.19K3.30N/AN/AN/A

In the previous week, Kooth's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company Overall Sentiment
Kooth Neutral
IQ-AI Neutral

21.0% of Kooth shares are held by institutional investors. 30.4% of Kooth shares are held by insiders. Comparatively, 66.0% of IQ-AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Kooth beats IQ-AI on 9 of the 12 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£65.49M£1.97B£7.83B£2.79B
Dividend YieldN/A3.89%2.47%5.11%
P/E Ratio12.0038.5133.0223.17
Price / Sales1.065.578.565.10
Price / Cash5.4215.6721.0120.23
Price / Book2.794.704.462.48
Net Income£4.00M-£19.09M£3.52B£5.88B
7 Day Performance-1.10%-7.84%-5.94%-1.44%
1 Month Performance-3.74%-5.72%-4.59%-2.86%
1 Year Performance40.13%-11.40%-1.94%7.76%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
N/AGBX 180
-2.7%
GBX 345
+91.7%
+40.1%£65.49M£62.02M12.00478
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
RENX
Renalytix
N/AGBX 5.47
flat
N/A-21.4%£36.64M£3MN/A102
COG
Cambridge Cognition
1.5876 of 5 stars
GBX 26
flat
GBX 56
+115.4%
-11.5%£14.04M£10.13MN/A74
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A+0.0%£9.00M£12.57MN/A74

Related Companies and Tools


This page (LON:KOO) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners